Pulmonx Corporation LUNG
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -48.12M | -53.21M | -54.00M | -56.75M | -56.94M |
| Total Depreciation and Amortization | 819.00K | 896.00K | 1.05M | 1.12M | 1.25M |
| Total Amortization of Deferred Charges | 304.00K | 188.00K | 53.00K | 49.00K | 46.00K |
| Total Other Non-Cash Items | 19.57M | 21.59M | 22.45M | 23.02M | 23.05M |
| Change in Net Operating Assets | -3.13M | 1.28M | -1.93M | 545.00K | 1.50M |
| Cash from Operations | -30.56M | -29.25M | -32.38M | -32.02M | -31.10M |
| Capital Expenditure | -112.00K | -160.00K | -452.00K | -550.00K | -877.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.80M | 14.32M | 30.93M | 45.11M | 43.48M |
| Cash from Investing | 8.69M | 14.16M | 30.48M | 44.56M | 42.60M |
| Total Debt Issued | 38.79M | 38.79M | -- | -- | -- |
| Total Debt Repaid | -37.11M | -37.10M | -100.00K | -98.00K | -97.00K |
| Issuance of Common Stock | 552.00K | 580.00K | 1.00M | 1.01M | 1.26M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -483.00K | -70.00K | -70.00K | -70.00K | -47.00K |
| Cash from Financing | 1.75M | 2.20M | 833.00K | 840.00K | 1.12M |
| Foreign Exchange rate Adjustments | 497.00K | -87.00K | -92.00K | -140.00K | -614.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.62M | -12.98M | -1.15M | 13.24M | 12.00M |